Enanta Pharmaceuticals, Inc. (ENTA)
14.30
-0.11
(-0.76%)
USD |
NASDAQ |
Feb 27, 16:00
14.24
-0.06
(-0.42%)
After-Hours: 20:00
Enanta Pharmaceuticals Research and Development Expense (TTM) : 99.94M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agios Pharmaceuticals, Inc. | 334.36M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 83.80M |
| BioMarin Pharmaceutical, Inc. | 700.97M |